Validation of Classical Ayurvedic formulations in treatment of COVID-19

To Evaluate the Efficacy of SUDARSHAN GHAN VATI and VYAGHRADI KWATH in the management of patients with COVID-19- A Pilot study.

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/026197

Enrollment

Registered

2020-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z208- Contact with and (suspected) exposure to other communicable diseases Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 3: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Sudarshan Ghanvati and Vyaghradi Kwath: Sudarshan Ghanvati 500 mg Tablet 2 TDS, Orally Vyaghradi Kwath 60 ml BD, Orally Duration- For 30 days. Control Intervention1: Conventional trea

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of COVID-19 positive cases with mild to moderate symptoms 2. Patients who can take medicine orally 3. Patients willing to provide signed informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with severe symptom 2. Immuno compromised patients 3. Pregnant / Lactating females 4. COVID-19 negative patients

Design outcomes

Primary

Measure	Time frame
Decrease in duration of conversion from COVID positive to negativeTimepoint: 4 Weeks	—

Secondary

Measure	Time frame
Improvement in Quality of LifeTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Amanpreet Kaur

Department of Indian Systems of Medicine, J&K, Jammu

contactdramanpreet@gmail.com9811933102

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026